“For now, we want to maintain our focus on the shortest path to commercialization, which we believe is best achieved by targeting treatment in the more aggressive chemotherapy regimens, in which cases of severe oral mucositis abound.”
They will go to FDA and propose a small phase 3 trial for cancer patients receiving high doses of cisplatin. The data was unreal yet small. The other drugs were much worse for this population. It’s smart and I believe they will get BTD and a deal will be inked the following week
TIAB - nice to see you bought shares today. good comment from your sister (Rad Onc) along with this comment i found....
" Considering the efficacy in HNC patients on high doses of cisplatin, this would seem like a logical pathway to structure a Phase 3 study to increase the odds of success and attracting a high-profile partner with the end-game being the first to market."
News 
Market Data 
Discover 
